Mike Burdon, Melanie Hingorani and Laura Coveney (RCOphth Policy Researcher) joined leaders from across the eye health sector at this half day seminar on 24 October 2017 to discuss quality, innovation and STPs. Mike presented an overview of The Way Forward research we published earlier this year. Mike described the impact that our ageing population

• 2 November 2017

The Royal College of Ophthalmologists (RCOphth) believes that ophthalmologists should have the discretion to prescribe Bevacizumab (Avastin) or alternatives such as Ranibizumab (Lucentis) or Aflibercept (Eylea), whichever is the most appropriate treatment of age related macular degeneration (AMD) for the patient, and provided the patient gives informed consent. The RCOphth has long petitioned a review

• 31 October 2017

The College welcomes the new NICE guideline for the management of cataracts in adults, which emphasises the importance of patient communication, shared decision making, minimising and managing risk to improve the quality and safety of patient care. The NICE guidelines also demonstrate the cost effectiveness of cataract surgery through scientific and financial modelling, meaning that

• 26 October 2017

• Tags | Cataract | cataract surgery | news | NICE

Prescription patterns and the effectiveness of artificial tears in dry eye disease in the real world Victoria Nowak, Jelle Vehof, Daren Hanumunthadu   The DRy eye Outcome and Prescription Study (DROPS) is a large observational multicentre study exploring the ‘real world’ effectiveness of artificial tears in dry eye disease. Our aim is to include at

• 16 July 2017

Novel use of Nanopore-sequencing for Rapid Identification of Causative Pathogens and their Resistance Genes in Endophthalmitis (Nano-PoRE study) Liying Low Liying is currently a Fight for Sight Clinical Research Fellow in the Academic Unit of Ophthalmology, University of Birmingham and is on the steering committee of the West Midlands Deanery Ophthalmology Trainee Research Network. She

• 16 July 2017